Pgx2 is a brand that specializes in the algorithmization of personalized pharmacotherapy, aiming to make drug therapy safe and efficient. Their mission is to provide safe and personalized drug therapy in every doctor's routine practice. Empirical selection of pharmacotherapy can lead to adverse drug reactions (ADRs) and pharmacoresistance, which can hinder effective treatment and cause harm to patients.

Pgx2 offers a bioinformatic cloud service for the analysis and interpretation of pharmacogenetic tests, providing insights into individual drug response and estimated risks of polypharmacy. By analyzing 154 polymorphisms, their software generates a detailed report that covers 52 drug groups, including over 5000 generics, across 8 medical specializations. Utilizing the expertise of a strong team of multidisciplinary pharmacogenetics, Pgx2 integrates deep learning technology and evidence-based data to support physicians in their daily practice.

For inquiries or further information, their contact details are provided